Intuitive Surgical (NASDAQ:ISRG) SVP Sells $2,365,593.75 in Stock

Intuitive Surgical, Inc. (NASDAQ:ISRG) SVP Iman Jeddi sold 5,625 shares of the firm’s stock in a transaction dated Monday, June 1st. The stock was sold at an average price of $420.55, for a total value of $2,365,593.75. Following the transaction, the senior vice president directly owned 6,463 shares in the company, valued at approximately $2,718,014.65. The trade was a 46.53% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Intuitive Surgical Stock Performance

NASDAQ:ISRG traded down $22.99 during mid-day trading on Tuesday, reaching $401.65. The stock had a trading volume of 3,029,105 shares, compared to its average volume of 2,241,224. The firm has a market capitalization of $142.25 billion, a price-to-earnings ratio of 49.89, a PEG ratio of 3.39 and a beta of 1.46. Intuitive Surgical, Inc. has a twelve month low of $411.83 and a twelve month high of $603.88. The business has a 50 day simple moving average of $452.19 and a 200 day simple moving average of $504.81.

Intuitive Surgical (NASDAQ:ISRG) last announced its quarterly earnings data on Tuesday, April 21st. The medical equipment provider reported $2.50 EPS for the quarter, beating analysts’ consensus estimates of $2.08 by $0.42. Intuitive Surgical had a net margin of 28.15% and a return on equity of 15.98%. The firm had revenue of $2.77 billion during the quarter, compared to the consensus estimate of $2.62 billion. During the same quarter last year, the firm earned $1.81 earnings per share. The firm’s revenue was up 23.0% compared to the same quarter last year. As a group, sell-side analysts expect that Intuitive Surgical, Inc. will post 8.57 earnings per share for the current year.

Wall Street Analysts Forecast Growth

Several research firms recently weighed in on ISRG. Weiss Ratings reissued a “hold (c)” rating on shares of Intuitive Surgical in a research report on Tuesday, May 19th. Deutsche Bank Aktiengesellschaft cut their price objective on Intuitive Surgical from $440.00 to $366.00 and set a “sell” rating on the stock in a research report on Tuesday. Wall Street Zen lowered Intuitive Surgical from a “buy” rating to a “hold” rating in a research report on Sunday, May 24th. The Goldman Sachs Group set a $558.00 price objective on Intuitive Surgical in a research report on Wednesday, May 27th. Finally, Citigroup raised Intuitive Surgical from a “neutral” rating to a “buy” rating and set a $590.00 price objective on the stock in a research report on Wednesday, March 11th. Nineteen investment analysts have rated the stock with a Buy rating, seven have given a Hold rating and one has issued a Sell rating to the company’s stock. According to data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $573.63.

Institutional Investors Weigh In On Intuitive Surgical

Several institutional investors and hedge funds have recently bought and sold shares of the business. Holos Integrated Wealth LLC acquired a new stake in shares of Intuitive Surgical during the 4th quarter valued at $25,000. Newbridge Financial Services Group Inc. boosted its stake in shares of Intuitive Surgical by 300.0% during the 4th quarter. Newbridge Financial Services Group Inc. now owns 44 shares of the medical equipment provider’s stock valued at $25,000 after buying an additional 33 shares during the period. Greykasell Wealth Strategies Inc. acquired a new stake in shares of Intuitive Surgical during the 3rd quarter valued at $27,000. Olistico Wealth LLC acquired a new stake in shares of Intuitive Surgical during the 4th quarter valued at $28,000. Finally, Caitlin John LLC acquired a new stake in shares of Intuitive Surgical during the 3rd quarter valued at $30,000. Institutional investors and hedge funds own 83.64% of the company’s stock.

About Intuitive Surgical

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.